Merck (MRK) Income After Tax (2009 - 2026)
Merck's Income After Tax came in at -$1.34 billion for Q2 2026, compared with $4.43 billion a year earlier.
Merck (MRK) Income After Tax (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Merck reported Income After Tax of $3.17 billion, down 80.7% year-over-year; for FY2025, it was $18.26 billion, up 6.6% from FY2024.
- Income After Tax carries a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
- Going back by year, Income After Tax was $17.13 billion in FY2024, $377 million in FY2023 (-97.4%), $14.53 billion in FY2022 (+17.5%) and $12.36 billion in FY2021 (+173.2%).
- The five-year range for quarterly Income After Tax is -$5.97 billion (Q2 2023) to $5.79 billion (Q3 2025).
- Year-over-year, Income After Tax increased in two of the last five quarters, with growth averaging 3.3%.
- The fastest year-over-year change in Income After Tax over five years came in Q2 2022 (growth of 225.3%), and the weakest in Q1 2023 (a decline of 34.4%).
- Business Quant data shows MRK's Income After Tax at -$4.24 billion (Q1 2026), $2.96 billion (Q4 2025) and $5.79 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.07 Bn |
| Jun 30, 2026 | -1.34 Bn |
| Mar 31, 2026 | -4.24 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 5.79 Bn |
| Jun 30, 2025 | 4.43 Bn |
| Mar 31, 2025 | 5.09 Bn |
| Dec 31, 2024 | 3.74 Bn |
| Sep 30, 2024 | 3.16 Bn |
| Jun 30, 2024 | 5.46 Bn |
| Mar 31, 2024 | 4.77 Bn |
| Dec 31, 2023 | -1.23 Bn |
| Sep 30, 2023 | 4.75 Bn |
| Jun 30, 2023 | -5.97 Bn |
| Mar 31, 2023 | 2.83 Bn |
| Dec 31, 2022 | 3.02 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.95 Bn |
| Mar 31, 2022 | 4.31 Bn |
| Dec 31, 2021 | 3.82 Bn |
Merck Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MRK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();